Tofacitinib for refractory ocular mucous membrane pemphigoid

Tofacitinib for refractory ocular mucous membrane pemphigoid

Purpose: To report the successful use of tofacitinib in the treatment of refractory ocular mucous membrane pemphigoid (MMP). Observations: Two patients with ocular MMP presented with refractory disease after failure of multiple therapies. Treatment with tofacitinib led to durable control of conjunct...

Full description

Bibliographic Details
Main Authors: Hayley James, Grace L. Paley, Richard Brasington, Philip L. Custer, Todd P. Margolis, Michael A. Paley
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:American Journal of Ophthalmology Case Reports
Subjects:
Ocular cicatricial pemphigoid
Mucous membrane pemphigoid
Tofacitinib
JAK
STAT
JAK inhibitor
Online Access:http://www.sciencedirect.com/science/article/pii/S2451993621001134

Internet

http://www.sciencedirect.com/science/article/pii/S2451993621001134

Similar Items